小口径人工血管短段间置术治疗高流量动静脉内瘘
本研究回顾性分析25例因高流量动静脉内瘘(≥1.5 L/min)导致高输出量心力衰竭或瘘静脉瘤样扩张的患者,采用5 mm人工血管行短段间置术。技术成功率100%,96.0%患者临床症状缓解,平均通路血流量降低52.4%。1、2、3年累积初级通畅率分别为76.2%±9.3%、70.4%±10.3%、58.1%±11.6%,次级通畅率分别为81.8%±8.2%、71.5%±9.9%、71.5%±9.9%。
要点
- 短段间置术可有效缓解高流量动静脉内瘘相关症状,技术成功率高。
- 术后1年初级通畅率76.2%,次级通畅率81.8%,3年仍可达58.1%和71.5%。
- 主要并发症为晚期血栓导致通路闭塞(21.7%)和移植物感染(4.3%)。
核心结论
- 小口径人工血管短段间置术是治疗终末期肾病患者高流量动静脉内瘘相关心脏症状和瘘静脉进行性扩张的简单、有效且持久的选项。
研究设计与样本
- 回顾性病例系列研究,纳入2004年6月至2017年4月期间在Saitama Medical Center接受5 mm人工血管短段间置术的25例高流量动静脉内瘘(≥1.5 L/min)患者。
主要发现
- 技术成功率为100%,24例(96.0%)患者临床症状缓解。
- 平均通路血流量降低52.4%。
- 1年、2年、3年累积初级通畅率分别为76.2%±9.3%、70.4%±10.3%、58.1%±11.6%。
- 1年、2年、3年次级通畅率分别为81.8%±8.2%、71.5%±9.9%、71.5%±9.9%。
- 中位随访3.9年期间,晚期血栓导致通路闭塞5例(21.7%),移植物感染1例(4.3%)。
关键数值与推荐
- 高流量动静脉内瘘定义为通路血流量≥1.5 L/min。
- 短段间置术使用5 mm人工血管。
- 手术指征包括心脏症状(16例)和瘤样扩张(9例)。
临床怎么用
- 对于高流量动静脉内瘘导致高输出量心力衰竭或瘘静脉进行性扩张的终末期肾病患者,可考虑采用小口径人工血管短段间置术以降低流量并缓解症状,同时保留原自体通路。
局限性
- 本研究为回顾性病例系列,样本量较小(25例),缺乏对照组,结果需更大规模研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The objective of this study was to evaluate the outcome of a short interposition using a small-diameter prosthetic graft as a flow-limiting procedure to manage symptomatic high-flow arteriovenous fistula (AVF). METHODS: A retrospective review of medical records on a case series was conducted. From June 2004 to April 2017, there were 25 patients with clinical symptoms of high output cardiac failure and progressive dilation of aneurysmal fistula vein due to high-flow AVF (≥1.5 L/min) who underwent short interposition with a 5-mm prosthetic graft at Saitama Medical Center. The primary outcome was the relief of clinical symptoms; other outcome measures included technical success, surgical complications, patency of vascular access, and postoperative changes in local and systemic hemodynamics as assessed by Doppler ultrasound. RESULTS: Twenty-five patients underwent short interposition for cardiac indications (n = 16) and aneurysmal dilation (n = 9). The technical success rate was 100%. The clinical symptoms were relieved in 24 patients (96.0%). Mean reduction in access blood flow was 52.4%. Cumulative primary unassisted patency rates (± standard error) at 1 year, 2 years, and 3 years were 76.2% ± 9.3%, 70.4% ± 10.3%, and 58.1% ± 11.6%, respectively. Secondary patency rates (± standard error) at 1 year, 2 years, and 3 years were 81.8% ± 8.2%, 71.5% ± 9.9%, and 71.5% ± 9.9%, respectively. Complications included access occlusion due to late thrombosis (n = 5 [21.7%]) and graft infection (n = 1 [4.3%]) in the median follow-up period of 3.9 years. CONCLUSIONS: Short interposition with a prosthetic graft is a simple, effective, and durable treatment option for end-stage renal disease patients with cardiac symptoms and progressive dilation of the fistula vein due to high-flow AVF, offering clinical symptom resolution while preserving the autologous behavior of the initial access.
引用
- Hashimoto T, Akagi D, Yamamoto S, et al. Short interposition with a small-diameter prosthetic graft for flow reduction of a high-flow arteriovenous fistula. J Vasc Surg. 2020. PMID: 32473337. doi:10.1016/j.jvs.2020.05.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。